drugIndia
Cart
Glyciphage-VG2 Tablet SR

Glyciphage-VG2 Tablet SR

Metformin (500mg) + Glimepiride (2mg) + Voglibose (0.2mg)

Franco-Indian Pharmaceuticals Pvt Ltd
Anti-Vomiting
127.12158.9020% OFF
In Stock
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
drugIndia verified
Save 66%
Best Alternative100% Match

Ozomet-VG2 Tablet SR

Ozone Pharmaceuticals Ltd

Voglibose 0.2mg
Ozomet-VG2 Tablet SR

Pack Size

1 units

Price

43.8420% off
Ozomet-VG2 Tablet SR is 100% same as Glyciphage-VG2 Tablet SR
Better ValueSame QualitySame Effectiveness

Save ₹83

that's 66% off!

composition
  1. Voglibose 0.2mg
  2. Glimepiride 2mg
  3. Metformin 500mg
Buy Now
127.1220% OFF
158.90

About This Medicine

Product description & overview

Glyciphage-VG2 Tablet SR: A Comprehensive Approach to Blood Sugar Management

Glyciphage-VG2 Tablet SR is a highly effective once-daily oral combination therapy for managing type 2 diabetes mellitus. This tablet delivers a potent triple-action approach with three carefully selected ingredients:

* Glimepiride (2mg): A sulfonylurea medication that stimulates insulin release from the pancreas, helping lower blood sugar levels.
* Metformin (500mg): An oral biguanide that improves insulin sensitivity and reduces glucose production in the liver.
* Voglibose (0.2mg): A selective α-glucosidase inhibitor that slows down the breakdown of carbohydrates, preventing their rapid absorption into the bloodstream and subsequently lowering postprandial blood sugar levels.

Glyciphage-VG2's unique combination provides a comprehensive solution for controlling both glycemic control and postprandial hyperglycemia. This ensures optimal blood sugar management while minimizing side effects compared to single-agent therapy.

Note: This product is intended for adults only and should not be used without consulting with a physician.

Active composition

Metformin 500 mg

+2 more active ingredients

About Metformin

Metformin is an oral antihyperglycemic agent used to manage type 2 diabetes mellitus. It works by decreasing glucose production in the liver and improving insulin sensitivity. Metformin is effective in controlling blood sugar levels and preventing diabetes-related complications. In summary, Metformin is vital for managing type 2 diabetes.

How It Works

Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.

Medicine Strength
500 mg

All Active Ingredients

Metformin500 mg
Glimepiride2 mg
Voglibose0.2 mg

Glimepiride

Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.

Voglibose

Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.

Dosage & How to Use

Dosage information not available. Please consult your doctor or pharmacist.

Safety Advice

Important precautions

Side Effect Occurrence

Based on clinical trials and patient reports.

Overall Tolerance

Most patients tolerate well

Only 2.3% reported effects

Common Side Effects

Headache8%
Nausea5%
Dizziness3%
Fatigue2%
Rash1%
Higher
Lower

Safety Advice

Alcohol

It is unsafe to consume alcohol with Glyciphage-VG2 Tablet SR.

High Risk

Pregnancy

Glyciphage-VG2 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Medical Advice

Driving

Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.

Exercise Caution

Liver

Glyciphage-VG2 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Glyciphage-VG2 Tablet SR may be needed. Please consult your doctor. Glyciphage-VG2 Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.

Regular Checkup

Breastfeeding

Glyciphage-VG2 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Consult Doctor

Kidney

Glyciphage-VG2 Tablet SR is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Glyciphage-VG2 Tablet SR is, however, not recommended in patients with severe kidney disease.

Regular Checkup

Customer Reviews

0 reviews for Glyciphage-VG2 Tablet SR

Products matching your search